NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Nutriband Inc. NTRB
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.0M
▼ 4.8% vs FY2024
EPS · FY25
$-2.58
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-125.6%
Net margin · FY25
-404.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.0M
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 404 cents on every revenue dollar this year.
Per share
USD -2.58
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-125.6%
Return on equity, FY2025
ROE
Operating margin-408.4%
Net margin-404.1%
Return on assets-109.6%
Each USD of equity lost 126 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+16.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−0.7%
+16.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+94.3%
Change, 10 years—
The share count grew 94% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 7.5M
total assets, end of FY2025
Total assetsUSD 7.5M
EquityUSD 6.7M
CashUSD 4.6M
Current ratio6.36×
Equity funds 88% of total assets.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
Income tax $B
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−2.58
−0.99
−0.69
−0.53
−0.80
−0.51
−0.50
−0.62
−0.14
−0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
−125.6
−162.9
−73.1
−43.9
−65.1
−80.5
−211.0
−263.7
−3695.2
−2599.2
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
37 of 38
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed